Moscow, May 27: Russian scientists have announced the development of a new vaccine designed to protect against a newly identified strain of the Ebola virus, according to officials in Moscow.
The research team said the vaccine has been created in response to evolving viral mutations and is aimed at strengthening preparedness against future outbreaks. Authorities noted that the development is part of ongoing efforts to improve global response tools for highly infectious diseases.
Health experts involved in the project stated that the candidate vaccine has shown promising early-stage results in laboratory and preclinical evaluations. Further studies are expected to assess its safety, immune response, and effectiveness before any broader deployment.
The announcement comes at a time when global health agencies continue to monitor Ebola activity in parts of Africa, where sporadic outbreaks have raised renewed concern over containment and rapid response capabilities.
Officials emphasized that the vaccine development is still in the research phase, with additional regulatory and clinical testing required before it can be approved for public use. They added that international cooperation will remain important in addressing emerging infectious disease threats.